Oncocount RGCC Test
Oncocount RGCC Test
What are Identified ?
CTCs (Circulating-Tumor-Cells)
Test Duration
21 – 25 days *
Test Type
Primary Assessment
Sample required
Blood sampleCancer Type
All type of CancersBlood sample Qty
15-20 ml peripheral whole bloodSample Test Report
DESCRIPTION
ONCOCOUNT TEST, as the name suggests it gives the count of Circulating Tumour Cells (CTC’s) present in blood.
This test gives the information on the presence of CTC’s and their concentration in blood. It helps in early detection of tumours, as well in the relapse or recurrence.
Please note, this test will report only the number of Circulating Cancer Tumour Cells (CTC’s). It does not include any other information concerning the CTC’s or Circulating Cancer Stem Cells (CSC’s) Immunophenotyping. This information should not be used to confirm a diagnosis of cancer.
SPECIMEN REQUIREMENT
15 ml of whole blood
Pre Test Counseling is given to the patient inorder to determine if CTC test is correct.
CTCs can be used to determine improved therapy monitoring.
CTCs can be used as a diagnostic and prognostic factor for cancer therapy.
CTCs can be used in classification of cancer patients based on risk scale.
CTCs can evaluate patient response to therapy.
CTCs can evaluate treatment efficacy.
CTCs can predict disease progression.
CTCs can be used to adjust therapeutic dosage.
Evaluates patient status post therapy.
Evaluates complete response.
Evaluates Maintenance therapy.